Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 9/20 | 0.53 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | MC4R | P32245 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HRH2 | P25021 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
| ▸ | PTPRB | P23467 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2068538 | 0.94 | KCNH2 (0.54) | KCNH2PABPC1CTSSCTSKMC4R | |
| SCHEMBL2069062 | 0.93 | KCNH2 (0.51) | KCNH2PABPC1CTSSCTSKMC4R | |
| SCHEMBL2070632 | 0.92 | KCNH2 (0.52) | KCNH2PABPC1CTSSCTSKPARP1 | |
| SCHEMBL2068274 | 0.90 | KCNH2 (0.48) | KCNH2PABPC1CTSSCTSKMC4R | |
| SCHEMBL2068837 | 0.90 | KCNH2 (0.55) | KCNH2PABPC1CTSSCTSKMC4R | |
| SCHEMBL18136315 | 0.87 | KCNH2 (0.51) | KCNH2PABPC1CTSSCTSKKMT2A | |
| SCHEMBL2070460 | 0.86 | KCNH2 (0.51) | KCNH2PABPC1CTSSCTSKP2RX7 | |
| SCHEMBL1049662 | 0.86 | KCNH2 (0.62) | KCNH2PABPC1CTSSCTSKP2RX7 | |
| SCHEMBL2068262 | 0.86 | KCNH2 (0.52) | KCNH2PABPC1CTSSCTSKMC4R | |
| SCHEMBL15340404 | 0.85 | KCNH2 (0.58) | KCNH2PABPC1CTSSCTSKP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9963454-B2 | Compounds and compositions for the treatment of parasitic disease | NOVARTIS AG (CH) | 2018-05-08 | — | — | US | disclosed |